Achilles Therapeutics (NASDAQ:ACHL) ADRs added ~42% in the premarket on Thursday after the U.K.-based biotech announced plans to explore strategic alternatives and close its CHIRON and THETIS ...
19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical ...
Achilles Therapeutics is discontinuing its TIL-based cNeT program and closing its Phase I/IIa CHIRON and THETIS clinical trials The company's stock surged 31.7% in response to this announcement.
The Jets got the news they expected Monday — pass rusher Jermaine Johnson tore his right Achilles tendon in Sunday’s win over the Titans and is expected to miss the remainder of the season.
LONDON - Achilles Therapeutics PLC (NASDAQ: ACHL), a clinical-stage biopharmaceutical company, announced today that it is halting the development of its TIL-based cNeT therapy and closing the ...
Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping its R&D in tumour-infiltrating lymphocyte (TIL) therapies for cancer and ...